Negative C-11-PIB PET Predicts Lack of Alzheimer's Disease Pathology in Postmortem Examination




Noora M. Scheinin, Maria Gardberg, Matias Röyttä, Juha O. Rinne

PublisherIOS PRESS

2018

Journal of Alzheimer's Disease

JOURNAL OF ALZHEIMERS DISEASE

J ALZHEIMERS DIS

63

1

79

85

7

1387-2877

DOIhttps://doi.org/10.3233/JAD-170569

https://research.utu.fi/converis/portal/detail/Publication/31093246



Our aim was to assess whether in vivo C-11-PIB negative memory-impaired subjects may nonetheless exhibit brain Alzheimer's disease (AD) pathology. We re-evaluated the PET images and systematically characterized the postmortem neuropathology of six individuals who had undergone clinically indicated amyloid PET. The single case with negligible amyloid-beta (A beta) pathology had Lewy body disease, where concomitant AD changes are often seen. Further, the subject's plaques were predominantly diffuse. The predictive value of a negative C-11-PIB scan appears to be good, even in memory-impaired populations. Our results suggest that considerable neuritic A beta plaque pathology in the absence of specific/cortical C-11-PIB binding upon PET is unlikely.

Last updated on 2024-26-11 at 22:23